Thursday, 3 December 2015

Senate Report Says Hep C Drug Maker Sought To Maximize Profits Despite Costs To Patients

Officials at Gilead Sciences, which makes the drugs Sovaldi and Harvoni that can cure hepatitis C infections, opted for a higher price tag even though they knew it would put the medications out of the reach of some patients and government programs, according to a Senate Finance Committee investigation.

No comments:

Post a Comment